• 作者：Ingrid Parra Salinas ; Anel Montes Limon ; Valle Recasens Flores ; Nuria Fern ; ez-Mosteirin ; Jose Antonio Garcia-Erce
• 关键词：Citafé ; resis ; Hemocromatosis hereditaria ; Flebotomí ; a ; Sobrecarga fé ; rrica
• 刊名：Medicina Clínica
• 出版年：4 March, 2014
• 年：2014
• 卷：142
• 期：5
• 页码：187-191
• 全文大小：281 K

Background and objective

Progressive increase of iron stores leads to the development of varied diseases, some of them irreversible. Until now, phlebotomy has been the cornerstone in the treatment of iron overload. Nevertheless, each erytrhocytapheresis procedure removes more than twice the volume of red cells and iron than phlebotomy, allowing to achieve iron depletion in shorter time. Our aim was to describe clinical features and analytical tests parameters of patients with iron overload, to analyze global and subsets results, to suggest predictive factors of response and to evaluate security of the procedure.

Patients and method

Descriptive, longitudinal and prospective study of 663 procedures corresponding to 35 patients (December 2002 to October 2011). Response was defined as a serum ferritine value lower than 50 ng/mL during two months. Statistical analysis was done with SPSS^庐 v 17.0 and the minimum level of statistical significance was defined as p-value < 0,05.

Results

Seventy-seven percent of patients reached response with 11 (interquartile range 1-42) erytrhocytapheresis procedures and at 11 (1-108) months. Eighty-seven point five percent of patients who did not achieve response had their ferritine values reduced in more than 50%. The decrease of all iron metabolism parameters was statistically significant. Statistically significant predictive factors of response to erytrhocytapheresis were: patients younger than 60 years-old, hereditary hemochromatosis cases, and patients who had received treatment with phlebotomies prior to erytrhocytapheresis.

Conclusions

Erytrhocytapheresis is a secure and effective procedure for iron depletion in patients with iron overload, especially in high risk hereditary hemochromatosis cases that do not respond to phlebotomies.